Tumor-Infiltrating Neutrophils and Non-Classical Monocytes May Be Potential Therapeutic Targets for HER2negative Gastric Cancer-Reference-Cited by-同舟云学术

Tumor-Infiltrating Neutrophils and Non-Classical Monocytes May Be Potential Therapeutic Targets for HER2negative Gastric Cancer

Published:2021 Issue:4 Volume:21 Page:
ISSN:1598-2629
Container-title:Immune Network
language:en
Short-container-title:Immune Netw

Author:

Jeong Juhee¹²^ORCID,Kim Duk Ki¹²,Park Ji-Hyeon³^ORCID,Park Do Joong³⁴⁵^ORCID,Lee Hyuk-Joon³⁴⁵^ORCID,Yang Han-Kwang³⁴⁵,Kong Seong-Ho³⁴⁵,Jung Keehoon¹²⁶^ORCID

Affiliation:

1. Department of Anatomy and Cell Biology, Seoul National University College of Medicine, Seoul 03080, Korea.

2. Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, Korea.

3. Department of Surgery, Seoul National University Hospital, Seoul 03080, Korea.

4. Department of Surgery, Seoul National University College of Medicine, Seoul 03080, Korea.

5. Cancer Research Institute, Seoul National University, Seoul 03080, Korea.

6. Institute of Allergy and Clinical Immunology, Seoul National University Medical Research Center, Seoul 03080, Korea.

Funder

National Research Foundation of Korea

Seoul National University College of Medicine

Seoul National University Hospital

Seoul National University

Publisher

The Korean Association of Immunobiologists

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Link

https://immunenetwork.org/pdf/10.4110/in.2021.21.e31

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of CLDN18.2 expression on effector cells mediating antibody-dependent cellular cytotoxicity in gastric cancer;Scientific Reports;2024-08-02

2. Normalization of the tumor microenvironment by harnessing vascular and immune modulation to achieve enhanced cancer therapy;Experimental & Molecular Medicine;2023-11-01

3. Proteogenomic landscape of human pancreatic ductal adenocarcinoma in an Asian population reveals tumor cell-enriched and immune-rich subtypes;Nature Cancer;2022-12-22

4. Prognostic Value of Lactate Dehydrogenase in Second-Line Immunotherapy for Advanced Esophageal Squamous Cell Carcinoma;Pathology and Oncology Research;2022-06-03

5. Beyond Immunosuppression: The Multifaceted Functions of Tumor-Promoting Myeloid Cells in Breast Cancers;Frontiers in Immunology;2022-03-03